Navigation Links
Amgen's Fourth Quarter 2008 Adjusted Earnings Per Share Increased 6 Percent to $1.06; Full Year 2008 Adjusted Earnings Per Share Increased 6 Percent to $4.55
Date:1/26/2009

124 (b) (21) (g) Write-off of acquired in-process R&D - - - 590 (590) (l) - Amortization of intangible assets 294 (294) (d) - 298 (295) (d) - (3) (m) Other charges 380 (92) (b) - 728 (694) (b) - (288) (e) (34) (e) --- ---- --- --- --- --- Total operating expenses 9,789 (978) 8,811 10,791 (2,090) 8,701 Operating income 5,214 978 6,192 3,980 2,090 6,070 Interest and other income and (expense), net 36 10 (b) 46 (19) 51 (n) 32 -- -- -- --- -- -- Income before income taxes 5,250 988 6,238 3,961 2,141 6,102 Provision for income taxes 1,054 299 (o) 1,353 795 92 (p) 1,298 411 (q) ----- --- ----- --- --- ----- Net income $4,196 $689 $4,885 $3,166 $1,638 $4,804 ====== ==== ====== ====== ====== ====== Earnings per share: Basic $3.92 $4.57 $2.83 $4.30 Diluted (r) $3.90 $4.55(a) $2.82 $4.29(a) Average shares used in calculation of earnings per share: Basic 1,070 1,070 1,117 1,117 Diluted (r) 1,075 1,074(a) 1,123
'/>"/>
SOURCE Amgen
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27

Related biology technology :

1. Beckman Coulter Announces Fourth Quarter 2008 Earnings to be Released on Monday, February 9, 2009, After Market Closes
2. Amgen Announces Webcast of 2008 Fourth Quarter and Full Year Financial Results
3. Caliper Life Sciences Announces Preliminary 2008 Fourth Quarter and Full Year Revenue Results
4. Cepheid Announces Preliminary 2008 Fourth Quarter and Full Year Revenue Results
5. Orexigen(R) Therapeutics Issued a Key Fourth U.S. Patent on Contrave(R)
6. BioMed Realty Trust Declares Fourth Quarter 2008 Common Stock and Preferred Stock Dividends
7. Martek Announces Fourth Quarter and FY 2008 Financial Results
8. Martek to Announce Fourth Quarter and Fiscal Year 2008 Results
9. Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results
10. Hill-Rom Reports Fourth Quarter Revenue Growth of 14.1 Percent to $424 Million and Adjusted Earnings Per Fully Diluted Share From Continuing Operations of $0.58, an Increase of 52.6 Percent From the Prior Year
11. Varian, Inc. Reports Strong Fourth Quarter 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... PARIS and NEW YORK ... data from its open-label pilot study of mazindol in ... Design, Development and Therapy in December 2014 . ... of mazindol in children with attention deficit/hyperactivity disorder" ( ... 2014 Dec 1;8:2321-2332. eCollection 2014 ) ...
(Date:12/22/2014)... , Dec. 22, 2014 GenomeDx Biosciences today ... Prostate Cancer Classifier, a genomic test for prostate cancer, ... high-risk men managed by radical prostatectomy without adjuvant therapy. ... is relatively uncommon, using tumor genomics to identify these ... disease is an important advance. The study has been ...
(Date:12/19/2014)... December 19, 2014 Bioject Medical ... and manufacturer of needle-free injection technology, today announced ... Immunomic Therapeutics, Inc. (“ITI”) for ITI to use ... its LAMP™ vaccine platform. , In the ... Worldwide license to the Biojector®-2000 that triggers based ...
(Date:12/19/2014)... , Dec. 19, 2014 Bina Technologies, Inc. (Bina, ... today that they have been acquired by Roche (SIX: ... a privately held company that provides a big data ... sequencing (NGS) data for the academic and translational research ... Unit, and will continue to focus on development of ...
Breaking Biology Technology:Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics 2Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics 3Study Published in European Urology Shows that the Decipher Prostate Cancer Classifier is Predictive of Rapid Metastasis in High-Risk Men who have had Prostate Surgery 2Study Published in European Urology Shows that the Decipher Prostate Cancer Classifier is Predictive of Rapid Metastasis in High-Risk Men who have had Prostate Surgery 3Bioject and Immunomic Therapeutics Enter into an Agreement for License of Needle-Free Technology for LAMP-vax Vaccines 2Bioject and Immunomic Therapeutics Enter into an Agreement for License of Needle-Free Technology for LAMP-vax Vaccines 3Bina Technologies is acquired by Roche. 2Bina Technologies is acquired by Roche. 3
... Sept. 19, 2010 -- A new type of nanoparticle ... the symbol on the flag of Israel has been discovered ... is a billionth of a meter.) The discovery, the researchers ... in diagnosing diabetes or provide a catalyst to capture the ...
... YORK, Sept. 21 Ramius Value and Opportunity Advisors LLC, ... Cypress Bioscience, Inc. (Nasdaq: CYPB ) has denied ...  Ramius owns 9.9% of the outstanding shares and has launched ... does not currently own for $4.25 per share in cash. ...
... and HAYWARD, Calif., Sept. 21 Oxford Resource Partners, ... Biotechnology, Inc. ("Mendel") today announced their collaborative agreement to ... varieties on land previously reclaimed from mining operations by ... the feasibility and economic viability of biomass production from ...
Cached Biology Technology:New nanomaterial, shaped like Stars of David, discovered at Hebrew University 2New nanomaterial, shaped like Stars of David, discovered at Hebrew University 3Cypress Denies Ramius' Legal Right to Stockholder List Materials 2Cypress Denies Ramius' Legal Right to Stockholder List Materials 3Oxford Resource Partners, LP and Mendel Biotechnology, Inc. Announce a Miscanthus Biomass Pilot Project in Ohio 2Oxford Resource Partners, LP and Mendel Biotechnology, Inc. Announce a Miscanthus Biomass Pilot Project in Ohio 3Oxford Resource Partners, LP and Mendel Biotechnology, Inc. Announce a Miscanthus Biomass Pilot Project in Ohio 4
(Date:12/17/2014)... , Dec. 16, 2014 Valencell, a ... its PerformTek biometric technology to industry leaders such as ... accurate, clinically validated, biometric wearable products. These products will ... in Las Vegas . ... is accurate, flexible and robust – with the clinical ...
(Date:12/17/2014)...  Automation is fundamentally transforming the travel experience ... international borders. Over the past decade, ePassports, biometric ... travelers to self process through border control via ... an increasing number of airports, seaports, and land ... to Maxine Most , Principal at Acuity ...
(Date:12/11/2014)... DUBLIN , Dec. 09, 2014 Research ... http://photos.prnewswire.com/prnh/20130307/600769 ( http://www.researchandmarkets.com/research/twhjll/biometrics_market ) ... Market in the APAC Region 2015-2019"  report to ... emerging in this market is advances in technology. ... to upgrade biometric solutions to the latest standard ...
Breaking Biology News(10 mins):Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
... New Haven, Conn.Environmental gains derived from the use of ... used to manufacture them, according to research published in ... Ecology . Hatice Şengl and colleagues at ... material purity requirements, lower tolerances for defects and lower ...
... of how carbon dioxide emissions absorbed into the oceans ... other natural resources has been commissioned by NOAA and ... the atmosphere through the burning of fossil fuels is ... Steven A. Murawski, director of scientific programs and chief ...
... highlighted a link between childhood obesity and a mother,s diet ... overweight expectant mothers are more likely to have babies with ... and lipid metabolic disorders later in life. Previous research ... are overweight. The research, published in the journal ...
Cached Biology News:Yale journal finds nanomaterials may have large environmental footprint 2NOAA and NSF commission national study of ocean acidification 2Overweight mums have chubby bubs 2